The asthma drug Xolair (omalizumab) improves asthma control, nearly eliminates seasonal flare-ups, and allows reductions in the doses of other asthma control medications in children as young as 6, according to a new study.
See original here:
Xolair Relieves Kids’ Seasonal Asthma Attacks: Study